Skip to content

    Ovarian Cancer Health Center

    Font Size

    Blood Test May Spot Inherited Ovarian Cancer

    Study Shows Gene Test May Be Able to Identify Women at Risk for Ovarian Cancer
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    March 9, 2011 (Orlando, Fla.) -- Nearly one in four ovarian cancers are inherited, say researchers who are developing a gene-based blood test to identify women with these hereditary cancers.

    The test, which looks for variations in 22 genes known or suspected to predispose women to ovarian cancer, isn't ready for prime time yet.

    But if results of the new study can be replicated and the test becomes commercially available, it would be a big advance over the current genetic screen, says study head Elizabeth Swisher, MD, an expert in medical genetics at the University of Washington in Seattle.

    The current test, which screens for the BRCA1 and BRCA2 genes, only spots about 10% to 15% of ovarian cancers, she tells WebMD.

    The new study included 284 women who were undergoing surgery to remove an ovarian or fallopian tube tumor. All provided blood samples for DNA testing.

    A total of 24% had a mutation in one or more of the 22 genes, which included BRCA 1 and BRCA2.

    About three-fourths of women who tested positive for a mutation had a family history of breast or ovarian cancer. (The same genes that increase a woman's risk of ovarian cancer are usually associated with increased breast cancer risk, too.)

    The results were presented at the Society of Gynecologic Oncology's Annual Meeting on Women's Cancer.

    Family Testing

    If the test does become available, who should be tested?

    "If there is a family history of ovarian or breast cancer, the woman with cancer should ideally be tested first," Swisher says.

    Then if she does test positive for the cancer, her daughter or other close female relatives may want to consider testing too, she says.

    Swisher says she expects the new test to cost about $1,000. That’s cheaper than the BRCA1/2 test, which costs $4,000.

    Jonathan M. Lancaster, MD, PhD, of the H. Lee Moffitt Cancer Center in Tampa, Fla., tells WebMD that the new research "contributes to our goal of personalized medicine."

    But there's still a long way to go, he says, noting that gene-based cancer blood screens that look good in early testing don't always hold up to scrutiny.

    Today on WebMD

    Ovarian cancer illustration
    What are the symptoms?
    doctory with x-ray
    Get to know the symptoms.
    cancer cell
    HPV is the top cause. Find out more.
    Lung cancer xray
    See it in pictures, plus read the facts.
    Integrative Medicine Cancer Quiz
    Lifestyle Tips for Depression Slideshow
    Screening Tests for Women
    Graphic of ovaries within reproductive system
    Ovarian Cancer Marker
    Pets Improve Your Health
    Vitamin D
    Healthy meal with salmon